<DOC>
	<DOCNO>NCT00492505</DOCNO>
	<brief_summary>RATIONALE : Sorafenib may stop growth tumor cell block enzymes need cell growth block blood flow tumor . Drugs use chemotherapy , tamoxifen cisplatin , work different way stop growth tumor cell , either kill cell stop divide . Giving sorafenib together tamoxifen cisplatin surgery may kill tumor cell remain surgery . PURPOSE : This phase II trial study side effect well give sorafenib together tamoxifen cisplatin work treat patient high-risk stage III melanoma .</brief_summary>
	<brief_title>Sorafenib , Tamoxifen , Cisplatin Treating Patients With High-Risk Stage III Melanoma</brief_title>
	<detailed_description>OBJECTIVES : - Compare relapse-free overall survival patient high-risk stage III melanoma receive adjuvant sorafenib tosylate , tamoxifen citrate , cisplatin vs historical data patient treat tamoxifen citrate cisplatin . - Compare toxicity regimens patient . OUTLINE : This pilot study . Patients stratify accord number positive lymph node identify surgery . Patients receive oral sorafenib tosylate twice daily day 1-28 , oral tamoxifen citrate twice daily day 1-7 , cisplatin IV 1 hour day 2 3 . Treatment repeat every 28 day 4 course absence disease progression unacceptable toxicity . After completion study therapy , patient follow periodically least 5 year .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Sorafenib</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Confirmed diagnosis melanoma Highrisk , stage III disease No measurable metastatic disease Has undergone surgery within past 8 week Surgically render disease free PATIENT CHARACTERISTICS : ECOG performance status 02 Creatinine clearance ≥ 50 mL/min OR creatinine ≤ 1.5 mg/dL Liver function test ≤ 3 time upper limit normal ANC ≥ 1,200/mm³ Hemoglobin ≥ 9.0 g/dL Platelet count ≥ 100,000/mm³ Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No myocardial infarction within past 6 month No congestive heart failure require medication No pulmonary disease require supplemental oxygen No dyspnea rest No active infection No chronic underlie immunodeficiency disease No serious illness , physician ' opinion , may compromise safety patient No cancer within past 5 year except nonmelanoma skin cancer cervical cancer No thromboembolic disease within past 6 month PRIOR CONCURRENT THERAPY : No prior tamoxifen citrate , sorafenib tosylate , cisplatin No concurrent radiotherapy surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>stage IIIA melanoma</keyword>
	<keyword>stage IIIB melanoma</keyword>
	<keyword>stage IIIC melanoma</keyword>
</DOC>